Brian J. Sodikoff

Christopher B. Ferenc

Gregory D. Miller

Matthew M. Holub

Gene Y. Kang

Rachel L. Schweers

Timothy P. Gonzalez

Dominick A. Conde

Liza M. Walsh

Katelyn O'Reilly

William E. Solander

Selina M. Ellis

Whitney Howard

Erin J. D. Austin

Jessica K. Formichella

Evan Krygowski

ANDA filing triggers Astellas' challenge to Sun's generic Xtandi®, asserting infringement of its core `androgen receptor inhibitor` patent for prostate cancer.

Prosecution History analysis

Examiner Search analysis

Invalidity Framework analysis

Name	Ratings
Astellas Pharma US Inc NPE	L4 A
Astellas Pharma Inc NPE	L4 A
Medivation Prostate Therapeutics LLC	L5 A
Medivation LLC	L5 A
Astellas US LLC NPE	L4 A
Regents of University of California NPE	L3 B

Name	Ratings
Venable LLP	L4 A
Dominick A. Conde	L5 A
William E. Solander	L3 A
Whitney Howard	L1 D
Erin J. D. Austin	-- -- --
Evan Krygowski	-- -- --
Walsh Pizzi Oreilly Falanga LLPLocal	L3 B
Liza M. Walsh	L4 A
Katelyn O'Reilly	L3 A
Selina M. Ellis	L2 E
Jessica K. Formichella	-- -- --

Name	Ratings
Rivkin Radler LLPLocal	L3 B
Gregory D. Miller	L3 A
Gene Y. Kang	L2 A
Timothy P. Gonzalez	-- -- --
Katten Muchin Rosenman LLP	L3 C
Brian J. Sodikoff	L5 D
Matthew M. Holub	L2 D
Christopher B. Ferenc	L2 E
Rachel L. Schweers	L1 D

2:22-cv-07357

Astellas Pharma Inc v. Sun Pharmaceutical Industries Inc